Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
28 Sept 2026, 9:00 am3d left
Published by the portal on this tender, for queries and grievance redressal.
Non Ionic Iso-Osmolar Iodinated contrast 320mg per ml 100 ml vial
Inj Iohexol 350 mg per ml in vial of 100 ml
Inj Iohexol 300 mg per ml in vial of 50 ml
Injection Iodinated Radiographic contrast with76 percent w per v Diatrizoate salts in ampoule of 20 ml
Iodine content 370 mg per ml
Inj Iodinated Radiographic contrast with 60 precent w per v Diatrizoate salts in ampoule of 20 ml
Iodine content 280 - 300 mg per ml
Inj Macrocyclic ionic Gadolinium based contrast agent for MRI 10 ml vial
GADOBUTROL 1.0 HIGH RELAXIVITY MACROCYCLIC MR CONTRAST MEDIA OF 5 ml VIAL - US FDA APPROVED
MRI contrast Gadolinium
10ml Vial
Inj Meglumine Gadoterate 0.5mmol per ml 10ml
Gadobutral 1.0 m mol per ml vial of 10 ml
9780554
GEM/2026/B/7939013
Two Packet Bid
Non Ionic Iso-Osmolar Iodinated contrast 320mg per ml 100
Kolkata, West Bengal
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹34 L
₹34 L
20%
Commandant, Command Hospital Eastern Command Kolkata, Department of Military Affairs, Indian Army, Ministry of Defence, (Maj Gen D Mukherjee)
Exempted
Yes
28 Sept 2026
7 Sept 2026
29 Sept 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Non Ionic Iso-Osmolar Iodinated contrast 320mg per ml 100 ml vial | Non Ionic Iso-Osmolar Iodinated contrast 320mg/ml 100 ml vial | 1,200 | No | Consignee2DGLP | 30 |
| 2 | Inj Iohexol 350 mg per ml in vial of 100 ml | Inj Iohexol 350 mg/ml in vial of 100 ml | 1,800 | Vial | Consignee2DGLP | 30 |
| 3 | Inj Iohexol 300 mg per ml in vial of 50 ml | Inj Iohexol 300 mg/ml in vial of 50 ml | 1,200 | AMP or VIAL | Consignee2DGLP | 30 |
| 4 | Injection Iodinated Radiographic contrast with76 percent w per v Diatrizoate salts in ampoule of 20 ml, Iodine content 370 mg per ml | Injection Iodinated Radiographic contrast with76% w/v Diatrizoate salts in ampoule of 20 ml, Iodine content 370 mg/ml | 480 | AMP or VIAL | Consignee2DGLP | 30 |
| 5 | Inj Iodinated Radiographic contrast with 60 precent w per v Diatrizoate salts in ampoule of 20 ml, Iodine content 280 - 300 mg per ml | Inj Iodinated Radiographic contrast with 60% w/v Diatrizoate salts in ampoule of 20 ml, Iodine content 280 - 300 mg/ml | 480 | AMP or VIAL | Consignee2DGLP | 30 |
| 6 | Inj Macrocyclic ionic Gadolinium based contrast agent for MRI 10 ml vial | Inj Macrocyclic ionic Gadolinium based contrast agent for MRI 10 ml vial | 480 | AMP or VIAL | Consignee2DGLP | 30 |
| 7 | GADOBUTROL 1.0 HIGH RELAXIVITY MACROCYCLIC MR CONTRAST MEDIA OF 5 ml VIAL - US FDA APPROVED | GADOBUTROL(1.0) HIGH RELAXIVITY MACROCYCLIC MR CONTRAST MEDIA OF 5 ml VIAL - US FDA APPROVED | 480 | NOS | Consignee2DGLP | 30 |
| 8 | MRI contrast Gadolinium , 10ml Vial | MRI contrast (Gadolinium ), 10ml Vial | 480 | NOS | Consignee2DGLP | 30 |
| 9 | Inj Meglumine Gadoterate 0.5mmol per ml 10ml | Inj Meglumine Gadoterate 0.5mmol/ml 10ml | 480 | Piece | Consignee2DGLP | 30 |
| 10 | Gadobutral 1.0 m mol per ml vial of 10 ml | Gadobutral 1.0 m mol per ml vial of 10 ml | 360 | Vial | Consignee2DGLP | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9780554.pdf
GEM_BID • 0.17 MB
origin241_2026-08-20-08-43-27_fb75604c545477b65ee52c37b5b21797.pdf
BOQ • 0.33 MB
boq_item_sample_file_241_2026-08-20-08-43-27_c4ea33f93253920bca2fdf3059b1835a.csv
BOQ • 0.00 MB
Origin241_2abaadef-ebbf-4b8c-ad1f1787198044185_buyer13chec.docx
GEM_OTHER • 0.01 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .